TransMedics (TMDX) Non-Current Debt (2018 - 2026)

TransMedics has reported Non-Current Debt for 9 years, with the latest figure at $44.7 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Debt fell 24.87% year-over-year to $44.7 million; the trailing twelve-month figure through Mar 2026 stood at $44.7 million (down 24.87% YoY), and the FY2025 full-year result was $49.6 million, down 16.48% from the prior year.
• Non-Current Debt for Q1 2026 stood at $44.7 million, down from $49.6 million in the prior quarter.
• The five-year high for Non-Current Debt was $59.5 million in Q2 2025, with the low at $35.3 million in Q1 2022.
• Average Non-Current Debt over 5 years is $54.6 million, with a median of $58.9 million recorded in 2023.
• Year-over-year, Non-Current Debt jumped 66.98% in 2022 and decreased 24.87% in 2026.
• Tracing TMDX's Non-Current Debt over 5 years: stood at $58.7 million in 2022, then gained by 0.63% to $59.1 million in 2023, then gained by 0.52% to $59.4 million in 2024, then fell by 16.48% to $49.6 million in 2025, then declined by 9.93% to $44.7 million in 2026.
• The last three Non-Current Debt figures came in at $44.7 million (Q1 2026), $49.6 million (Q4 2025), and $54.6 million (Q3 2025), per Business Quant data.

Peer Comparison